SPRY   $13.99  4.56% Market Closed After Close 13.64 -2.50%

ARS Pharmaceuticals Inc
Last Events:

2023-08-09 Trend pattern changed from симметричный треугольник to нисходящий треугольник.

2023-08-09 Signal in RSI changed from bullish recovery to bearish. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-09 Signal in EMA100 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-09 Signal in EMA20 changed from bullish reversal to bearish reversal. The price is trying to cross down the moving average line If the intersection will be successful, then a downside trend can be formed.

2023-08-06 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-08-06 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: entrance to the overbought zone.

2023-08-05 Signal in Stochastic changed from bullish to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: main and signal line crossing.

2023-08-03 Signal in RSI changed from bullish to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.


Current temperature: 17.17
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 3
Target Price Mean 29
Mean unverified/preliminary 29 / 29
Target Price Low / High 26 / 35
Median / STD DEV 26 / 5.20
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy Buy ActivelyBuy
rsi ActivelyBuy ActivelyBuy None
macd None None None
stoch Sell None None
ma20 ActivelyBuy Buy None
ma50 Sell None None
ma100 ActivelyBuy Buy ActivelyBuy
Candlestick PatternNov. 22, 2024 Bullish Engulfing - is characterized by a large white body engulfing a preceding smaller black body, which appears during a downtrend. Considered to be a bullish reversal pattern.
ISIN US82835W1080
ceo Mr. Richard Lowenthal M.B.A., M.S., MSMSEL
Website https://ars-pharma.com
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.